Tenet Healthcare Corporation (NYSE:THC) Receives $250.56 Average Price Target from Analysts

Shares of Tenet Healthcare Corporation (NYSE:THC) have been given an average rating of “Moderate Buy” by the twenty-two research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, eighteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $250.5556.

THC has been the subject of a number of recent research reports. Jefferies Financial Group increased their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. UBS Group lifted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Barclays boosted their price objective on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Finally, Leerink Partners raised their target price on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th.

Tenet Healthcare Trading Down 1.8%

Shares of THC opened at $199.74 on Friday. Tenet Healthcare has a 52-week low of $109.82 and a 52-week high of $247.21. The stock has a market cap of $17.37 billion, a PE ratio of 12.89, a price-to-earnings-growth ratio of 0.98 and a beta of 1.39. The firm’s fifty day moving average is $213.92 and its two-hundred day moving average is $205.23. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 46,517 shares of company stock valued at $10,943,111 over the last ninety days. Company insiders own 0.81% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Several large investors have recently modified their holdings of THC. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the 3rd quarter worth $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare during the fourth quarter worth about $29,000. William B. Walkup & Associates Inc. acquired a new stake in shares of Tenet Healthcare during the third quarter valued at about $32,000. Finally, Westside Investment Management Inc. raised its stake in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.